| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.1M | -8.5% |
| Cost of Revenue | $4.3M | -34.4% |
| Gross Profit | -$132K | +93.4% |
| R&D Expense | $281K | -1.1% |
| SG&A Expense | $2.5M | +37.4% |
| Operating Income | -$3.2M | +29.4% |
| Interest Expense | $27K | -0.3% |
| Pre-tax Income | -$3.2M | +32.7% |
| Net Income | -$3.2M | +32.7% |
| EPS (Basic) | -$0.74 | -174.1% |
| EPS (Diluted) | -$0.74 | -174.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $345K | -42.5% |
| Accounts Receivable | $241K | +4.0% |
| Inventory | $1.6M | -28.5% |
| Current Assets | $2.3M | -28.3% |
| Total Assets | $31.0M | +108.2% |
| Current Liabilities | $7.4M | +47.5% |
| Total Liabilities | $8.3M | +15.7% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $148K | +131.8% |
| Capital Expenditures | $59K | +54.4% |
| Investing Cash Flow | -$137K | +53.0% |
| Financing Cash Flow | -$294K | -1174.9% |
| Free Cash Flow | $89K | +117.6% |
| $22.7M |
| +193.5% |